Results 171 to 180 of about 11,979 (257)

Corrigendum: Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprogramming of the tumour microenvironment. [PDF]

open access: yesFront Immunol
Jennings VA   +17 more
europepmc   +1 more source

Telomerase-specifi c oncolytic virotherapy for human hepatocellular carcinoma

open access: hybrid, 2008
Yuemin Li   +10 more
openalex   +1 more source

Mutations in the Glycoprotein of Vesicular Stomatitis Virus Affect Cytopathogenicity: Potential for Oncolytic Virotherapy [PDF]

open access: bronze, 2011
Valérie Janelle   +4 more
openalex   +1 more source

Oncolytic adenovirus encoding variant interleukin-2 combined with chemotherapy enables PD-L1 inhibition in pancreatic cancer models. [PDF]

open access: yesCancer Immunol Immunother
Pakola SA   +18 more
europepmc   +1 more source

Emerging delivery strategy for oncolytic virotherapy

open access: yesMolecular therapy. Oncology
Jiao Zhu   +4 more
semanticscholar   +1 more source

Oncolytic Viruses as a Novel Therapeutic Approach for Colorectal Cancer: Mechanisms, Current Advances, and Future Directions. [PDF]

open access: yesCancers (Basel)
Pérez-Domínguez F   +4 more
europepmc   +1 more source

Comparative safety and efficacy of oncolytic virotherapy for the treatment of individuals with malignancies: a systematic review, meta-analysis, and Bayesian network meta-analysisResearch in context

open access: yesEClinicalMedicine
Summary: Background: Oncolytic virotherapy (OV) is an innovative immunotherapy strategy. A comprehensive understanding of oncolytic viruses is essential for advancing research and clinical practice.
Poyee Lau   +4 more
doaj  

Oncolytic virotherapy provides a potent therapy option for squamous bladder cancer. [PDF]

open access: yesSci Rep
Pannhausen J   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy